Poniard Pharmaceuticals Inc. (PARD)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

7000 SHORELINE COURT SO. SAN FRANCISCO, CA 94080

Poniard Pharma develops and commercializes cancer therapy products. This biotechnology company's major research and development program is picoplatin (NX 473), a next generation platinum-based cancer therapy designed to overcome platinum resistance in the treatment of solid tumors.

Data as of 2021-05-08 10:29:16 -0400
Market Cap87.251 Thousand Shares Outstanding1.499 Million Avg 30-day Volume4.762 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low0.122 / 0.031 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PARD instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PARD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PARD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PERRY MICHAEL S PRESIDENT & CMO

  • Officer
8,920 2012-03-27 0

JACKSON MICHAEL K INTERIM CFO

  • Officer
5,668 2012-03-27 0

MARTELL RON CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
548,073 2011-10-06 0

LYONS GARY A

  • Director
206,145 2011-07-11 0

MCMAHON GERALD PHD

  • Director
73,826 2011-06-09 0

CRAVES FRED B

  • Director
642,259 2011-06-09 0

STEVENS DAVID R

  • Director
55,963 2011-06-09 0

DICKSON E ROLLAND

  • Director
48,906 2011-06-09 0

GOLDFISCHER CARL

  • Director
318,962 2011-06-09 0

BASSO ROBERT S

  • Director
41,145 2011-06-09 0

LITTAUER ROBERT K

  • Director
36,145 2011-06-09 0

SIMON NICHOLAS J III

  • Director
  • 10% Owner
6,435,538 2010-06-09 0

WEAVER GREGORY L CHIEF FINANCIAL OFFICER

  • Officer
0 2010-02-04 0

EVNIN LUKE

GALAKATOS NICHOLAS

HENNER DENNIS

STEINMETZ MICHAEL

GADICKE ANSBERT

WHEELER KURT

  • 10% Owner
6,363,249 2009-11-05 0

MPM BIOVENTURES III LLC

MPM BIOVENTURES III PARALLEL FUND, LP

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES III LP

MPM BIOVENTURES III GP LP

MPM BIOVENTURES III QP LP

MPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLC

  • 10% Owner
6,363,249 2009-11-05 0

DE JAGER ROBERT CHIEF MEDICAL OFFICER

  • Officer
0 2008-12-18 0

WIGHT ANNA L VP LEGAL

  • Officer
0 2008-01-03 0

KARLIN DAVID A SR. VP, CLINICAL DEVLPT & REG

  • Officer
0 2008-01-03 0

LOEWY CAROLINE M CFO

  • Officer
0 2008-01-03 0

KWOK CHENI VP, BUS. DEVLPT.

  • Officer
0 2008-01-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 22:15:03 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 21:45:02 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 21:15:03 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 20:45:03 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 20:15:04 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 19:45:03 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 19:15:02 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 18:45:03 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 18:15:04 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 17:45:03 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 17:15:03 UTC -0.27 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 16:45:03 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 16:15:03 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 15:45:03 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 15:15:03 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 14:45:03 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 14:15:03 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 13:45:03 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 13:15:02 UTC -0.25 0.3 100
PONIARD PHARMACEUTICALS INC PARD 2021-05-03 12:45:02 UTC -0.25 0.3 100

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments